Early Pregnancy Ultrasound Measurements and Prediction of First Trimester Pregnancy Loss.
NCT ID: NCT06540092
Last Updated: 2024-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
126 participants
OBSERVATIONAL
2024-03-19
2024-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biochemical Versus Ultrasound Findings as Predictors of Fetal Loss in Cases of First Trimester Threatened Miscarriage
NCT03797508
Ultrasound Predictors of Early Pregnancy Failure in Patients With Recurrent Pregnancy Loss
NCT03178682
Biochemical, 2D and 3D Ultrasonographic Predictors of Pregnancy Outcome in Women With Threatened Abortion
NCT06797557
Fetal Fibronectin as a Predictor of Successful Induction of Mid-trimester Abortion
NCT02694198
FGR Diagnostic Criteria in Predicting Adverse Neonatal Outcomes
NCT04933396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound
ultrasound measurements during first trimester
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age: 6 - 13 weeks of gestations.
* Singlton or multifetal pregnancy.
* Any mode of conception included spontaneous, after superovulation with clomiphene citrate or letrozole with, or without, intrauterine insemination (IUI), and in vitro fertilization (IVF) after superovulation with gonadotropins.
Exclusion Criteria
* Pregnant women above 13 weeks gestation.
* Patient with symptoms of threatened abortion or ectopic pregnancy at the initial antenatal visit.
* Patient unable to come for follow up.
* Any medical disorders as DM, HTN, …
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kasr El Aini Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hend Mahmoud Abdelghany
Lecturer of Obstetrics and Gynecology, Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
kasr Al Aini, Faculty of Medicine, Cairo University
Cairo, Old Cairo, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS-521-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.